World Class Laboratory

PuraPharm possesses one of the strongest capability in the research and development of CCMG combo formulae products and operate the most advanced production technologies among the five CFDA-licensed CCMG product manufacturers in China. In 2009, our testing laboratory was granted accreditation by the China National Accreditation Service for Conformity Assessment (CNAS), a member of the International Laboratory Accreditation Corporation (ILAC). This accreditation standard is an international multilateral recognition system equivalent to an accreditation in accordance with the ISO 17025 standards. Such accreditation and certification guarantee the competence, practice and specifications of our PuraPharm verified laboratory meets internationally recognized standards . Our CNAS laboratory accreditation also means that the testing laboratory of PuraPharm meets the international standards of both International Laboratory Accreditation Cooperation (ILAC) and Asia Pacific Laboratory Accreditation Cooperation (APLAC). We are the first CFDA-licensed CCMG product manufacturer qualified to issue safety reports recognized by over 70 countries around the world through our in-house China National Accreditation Service for Conformity Assessment (CNAS) ISO 17025 laboratory.

For details, please refer to CNAS official website at http://eng.cnas.org.cn/index.html

In addition, our research facilities were awarded by the Department of Science and Technology of Guangxi Zhuang Autonomous Region as the “Guangxi Modernized CCMG Product Engineering Technology Research Centre (廣西現代中藥配方顆粒工程技術研究中心)”.